Dasatinib With Ifosfamide, Carboplatin, Etoposide: A Pediatric Phase I/II Trial
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Dasatinib (Primary) ; Carboplatin; Etoposide phosphate; Ifosfamide
- Indications CNS cancer; Ewing's sarcoma; Germ cell and embryonal neoplasms; Hepatic tumours; Lymphoma; Neuroblastoma; Osteosarcoma; Renal cancer; Rhabdomyosarcoma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 10 Feb 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
- 10 Aug 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.
- 31 Dec 2015 Planned primary completion date changed from 1 Feb 2016 to 1 Sep 2016, as reported by ClinicalTrials.gov.